Flotufolastat F-18 Gallium
Sponsors
Northwestern University, Mayo Clinic, City of Hope Medical Center, Emory University, Jonsson Comprehensive Cancer Center
Conditions
Biochemically Recurrent Prostate CarcinomaLocalized Prostate CarcinomaOligometastatic Prostate CarcinomaProstate AdenocarcinomaProstate CarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8
Early Phase 1
rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance
RecruitingNCT05852041
Start: 2023-06-07End: 2035-06-07Target: 40Updated: 2025-05-22
An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial
RecruitingNCT06813898
Start: 2025-02-17End: 2032-02-01Target: 27Updated: 2025-02-18
Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
RecruitingNCT07164027
Start: 2025-11-14End: 2037-01-28Target: 30Updated: 2026-03-10
Phase 2
An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique
RecruitingNCT06865768
Start: 2025-04-18End: 2029-12-31Target: 90Updated: 2025-06-24
Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
RecruitingNCT07025369
Start: 2025-08-25End: 2026-12-31Target: 30Updated: 2026-03-13
Unknown Phase
Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer
RecruitingNCT06389786
Start: 2024-06-11End: 2026-05-31Target: 50Updated: 2025-10-24
[18F]-rhPSMA PET-CT Imaging Performance in Patients With Prostate Cancer
RecruitingNCT06580015
Start: 2025-03-25End: 2027-01-09Target: 20Updated: 2025-07-18